Latest updates for Merck

Fresh curated links around Merck are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Analyst Report: Merck & Co Inc
  • Pharma giant Merck to slash 54 jobs at Rahway headquarters
  • Merck is a buy as strong cancer drug pipeline offsets Keytruda patent expiration, Morgan Stanley says

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

finance.yahoo.com /4 weeks ago

Analyst Report: Merck & Co Inc

Read source
roi-nj.com /16 hours ago

Pharma giant Merck to slash 54 jobs at Rahway headquarters

The pharmaceutical company Merck & Co. has notified state officials that it will lay off 54 workers at its Rahway headquarters, according to a September filing with the New Jer...

Read source
cnbc.com /2 weeks ago

Merck is a buy as strong cancer drug pipeline offsets Keytruda patent expiration, Morgan Stanley says

Merck, which makes the popular cancer treatment Keytruda, is poised to gain ground as its pipeline drugs get close to coming to market, per Morgan Stanley.

Read source
cafepharma.com /1 month ago

FU MERCK!!

FU MERCK!! Anonymous (not verified) Thu, 07/23/2026 - 15:21 field_thread_url https://cafepharma.com/boards/threads/fu-merck.486959/ boar...

Read source
finance.yahoo.com /3 weeks ago

Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engin...

Read source
seekingalpha.com /1 month ago

Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions

Read source
fiercebiotech.com /3 weeks ago

Merck KGaA lays off 20 staffers in latest blow to US research team

The Massachusetts research site for Merck KGaA’s North American division, EMD Serono, has decided to hand pink slips to 20 staffers, Fierce has learned.

Read source
fiercebiotech.com /1 month ago

Merck stages expanded access to monthly HIV PrEP pill ahead of approval

Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory subm...

Read source
roi-nj.com /2 weeks ago

Merck, Moderna report positive Phase 3 melanoma results for Keytruda combination

Rahway-based Merck and Moderna said Aug. 19 that a Phase 3 trial of an investigational mRNA-based cancer therapy used in combination with Keytruda met its primary and key secondary...

Read source
pharmexec.com /1 week ago

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

Read source
cafepharma.com /1 month ago

PCSK9 Pill - When Will Merck Start The Hiring Process ?

PCSK9 Pill - When Will Merck Start The Hiring Process ? Anonymous (not verified) Mon, 07/20/2026 - 15:19 field_thread_url https://cafepharma.com/boards/thr...

Read source
cafepharma.com /1 month ago

PCSK9 Pill - When Will Merck Start The Hiring Process ?

PCSK9 Pill - When Will Merck Start The Hiring Process ? Anonymous (not verified) Wed, 07/22/2026 - 15:21 field_thread_url https://cafepharma.com/boards/thr...

Read source
seekingalpha.com /1 month ago

Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript

Read source
fiercebiotech.com /1 month ago

Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combination

After keeping tight-lipped for nearly two years, Merck & Co. briefly dropped the first concrete hint as to where it intends to take its PD-1xVEGF bispecific antibody—before qui...

Read source
fiercebiotech.com /1 month ago

Merck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trials

A phase 2 trial of Merck & Co.’s anti-TL1A monoclonal antibody has missed its primary endpoint, closing off one avenue for expansion of an asset acquired in a $10.8 billion tak...

Read source
pharmexec.com /3 weeks ago

<![CDATA[M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration wit...

Read source
fiercebiotech.com /1 month ago

Merck KGaA institutes in-office requirement for US research team that could lead to 70 layoffs

Merck KGaA’s U.S. research site has instituted a new in-office work requirement that may lead to the imminent departure of as many as 70 staffers.

Read source
fiercebiotech.com /1 week ago

Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies

Eli Lilly has struck a deal to acquire Merida Biosciences for up to $2.875 billion, establishing a beachhead in efforts to treat disease through the selective degradation of pathog...

Read source
njbiz.com /1 month ago

Merck wins FDA approval for oral LDL cholesterol drug

Merck won FDA approval for Lipfendra, the first oral PCSK9 inhibitor for adults with high LDL cholesterol and hypercholesterolemia. The post Merck wins FDA approval for oral LDL ch...

Read source
labiotech.eu /1 month ago

Merck after Keytruda: what the pipeline looks like 

Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry. The post Merck after Keytruda: what the pipeline looks like  appe...

Read source
biopharmadive.com /1 month ago

Merck wins first approval of a PCSK9 cholesterol pill

The speedy clearance of Lipfendra is an important milestone for Merck and the result of a controversial voucher program put in place by former FDA commissioner Marty Makary.  

Read source
pharmexec.com /1 week ago

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences]]>

Read source
cafepharma.com /1 month ago

Hoechst-Roussel

Hoechst-Roussel Anonymous (not verified) Thu, 07/16/2026 - 12:16 field_thread_url https://cafepharma.com/boards/threads/hoechst-roussel.12347/...

Read source
pharmexec.com /1 week ago

<![CDATA[Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion]]>

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Merck

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

njbiz.com

Recent coverage from public sources
Public source

search.cnbc.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source